STRS Ohio’s Vor Biopharma VOR Stock Holding History

STRS Ohio’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-135	Closed	-$16K	–	2305
2022 Q1	$16K	Hold	135	–	–	﹤0.01%	2063
2021 Q4	$31K	Hold	135	–	–	﹤0.01%	2064
2021 Q3	$42K	Hold	135	–	–	﹤0.01%	2097
2021 Q2	$50K	Hold	135	–	–	﹤0.01%	2109
2021 Q1	$116K	Buy	+135	New	+$114K	﹤0.01%	1916

Other funds holding VOR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

STRS Ohio's VOR Position: Q2 2022 in Review

STRS Ohio sold out of Vor Biopharma (VOR) in Q2 2022, closing a stake of 135 shares — an estimated $16K sold.

STRS Ohio first reported a position in VOR in Q1 2021 and held it in 5 quarters. The position peaked at $116K in Q1 2021. 49 funds tracked by Wall St. Rank hold VOR as of Q2 2022.

STRS Ohio reported no remaining Vor Biopharma position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 135 Vor Biopharma shares in Q2 2022, an estimated $16K.
STRS Ohio first reported a position in Vor Biopharma in Q1 2021 and held it in 5 quarters.
STRS Ohio's Vor Biopharma position peaked at $116K in Q1 2021.
49 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.